Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Botox Injection for Lower Extremity Lengthening and Deformity Correction Surgery (BOLLD)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Reggie Hamdy, MD, Shriners Hospitals for Children
ClinicalTrials.gov Identifier:
NCT00412035
First received: December 13, 2006
Last updated: December 22, 2014
Last verified: December 2014